Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun 28;336(7659):1472-4.
doi: 10.1136/bmj.39590.732037.47.

What is missing from descriptions of treatment in trials and reviews?

Paul Glasziou  1 , Emma Meats, Carl Heneghan, Sasha Shepperd
Affiliations

What is missing from descriptions of treatment in trials and reviews?

Paul Glasziou et al. BMJ. .

Abstract

Replicating non-pharmacological treatments in practice depends on how well they have been described in research studies

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

None
Fig 1 Selecting studies for inclusion in one year’s issues of Evidence-Based Medicine
None
Fig 2 Percentage of studies with sufficient description of treatment initially (based only on the published paper) and after supplementary information was obtained.
See this image and copyright information in PMC

Similar articles

  • Ensuring inclusion of research reports in systematic reviews.
    Dijkers MP. Dijkers MP. Arch Phys Med Rehabil. 2009 Nov;90(11 Suppl):S60-9. doi: 10.1016/j.apmr.2009.04.026. Arch Phys Med Rehabil. 2009. PMID: 19892076
  • Evaluation of the evidence.
    Holmes MA. Holmes MA. Vet Clin North Am Small Anim Pract. 2007 May;37(3):447-62. doi: 10.1016/j.cvsm.2007.01.004. Vet Clin North Am Small Anim Pract. 2007. PMID: 17466749 Review.
  • The Tamiflu trials.
    Loder E, Tovey D, Godlee F. Loder E, et al. BMJ. 2014 Apr 9;348:g2630. doi: 10.1136/bmj.g2630. BMJ. 2014. PMID: 24811414 No abstract available.
  • Tissue viability.
    Gebhardt KS. Gebhardt KS. J Tissue Viability. 1998 Oct;8(4):2. J Tissue Viability. 1998. PMID: 10480964 No abstract available.
  • Clinical trials: a journey of discovery.
    Cross RD, Nears A. Cross RD, et al. Nurs Stand. 2000 Jun 14-20;14(39):44-7. doi: 10.7748/ns2000.06.14.39.44.c2857. Nurs Stand. 2000. PMID: 11974331 Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 2006;185:263-7. - PubMed
    1. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457-65. - PubMed
    1. Dopson S, Locock L, Chambers D, Gabbay J. Implementation of evidence-based medicine: evaluation of the promoting action on clinical effectiveness programme. J Health Serv Res Policy 2006;6:23-31. - PubMed
    1. Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations. Med Care 1996;34:873-89. - PubMed
    1. Glasziou P, Haynes B. The paths from research to improved health outcomes. ACP J Club 2005;142:A8-10. - PubMed

Publication types

MeSH terms